Virtu Financial’s Altimmune ALT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-70,540
Closed -$217K 1558
2026
Q1
$217K Buy
70,540
+12,063
+21% +$51.2K 0.01% 984
2025
Q4
$211K Buy
58,477
+10,409
+22% +$45.4K 0.01% 996
2025
Q3
$181K Sell
48,068
-219,710
-82% -$848K 0.01% 937
2025
Q2
$1.04M Buy
+267,778
New +$1.45M 0.05% 324
2025
Q1
Sell
-86,831
Closed -$626K 1313
2024
Q4
$626K Sell
86,831
-22,928
-21% -$175K 0.03% 432
2024
Q3
$674K Buy
+109,759
New +$744K 0.04% 360
2020
Q3
Sell
-38,460
Closed -$412K 1012
2020
Q2
$412K Buy
+38,460
New +$211K 0.05% 432
2019
Q4
$29K Sell
15,248
-15,186
-50% -$28K ﹤0.01% 1275
2019
Q3
$59K Buy
+30,434
New +$67.5K ﹤0.01% 1170
2019
Q1
Sell
-16,274
Closed -$34K 1383
2018
Q4
$34K Buy
+16,274
New +$57.6K ﹤0.01% 1314

Other funds holding ALT

Virtu Financial's ALT Position: Q2 2026 in Review

Virtu Financial sold out of Altimmune (ALT) in Q2 2026, closing a stake of 70,540 shares — an estimated $217K sold.

Virtu Financial first reported a position in ALT in Q4 2018 and held it in 10 quarters. The position peaked at $1.04M in Q2 2025. 210 funds tracked by Wall St. Rank hold ALT as of Q2 2026.

  • Virtu Financial reported no remaining Altimmune position as of Q2 2026 after selling out during the quarter.
  • Virtu Financial sold 70,540 Altimmune shares in Q2 2026, an estimated $217K.
  • Virtu Financial first reported a position in Altimmune in Q4 2018 and held it in 10 quarters.
  • Virtu Financial's Altimmune position peaked at $1.04M in Q2 2025.
  • 210 funds tracked by Wall St. Rank held Altimmune as of Q2 2026.

Based on Virtu Financial's 13F filing for Q2 2026, filed 13 Aug 2026.